{"id":3576,"date":"2026-11-14T19:21:54","date_gmt":"2026-11-14T19:21:54","guid":{"rendered":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/?p=3576"},"modified":"2026-11-14T19:21:54","modified_gmt":"2026-11-14T19:21:54","slug":"key-updates-from-the-pharmaceutical-and-biotech-industry-recent-trends-and-insights","status":"publish","type":"post","link":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/key-updates-from-the-pharmaceutical-and-biotech-industry-recent-trends-and-insights\/","title":{"rendered":"Key Updates from the Pharmaceutical and Biotech Industry: Recent Trends and Insights"},"content":{"rendered":"<p>The pharmaceutical and biotech world is constantly evolving, and several important discussions and trends have recently come to light. Here\u2019s a breakdown of the latest developments in simple terms, explained by a pharmacist for easy understanding. <\/p>\n<p>**Podcast Highlights from BIO-Europe Conference:**<br \/>\nRecently, experts Annabel Kartal-Allen and Jam Bensilum shared key takeaways from the BIO-Europe conference in a podcast. They discussed important topics like the rise of artificial intelligence (AI) in drug development, China\u2019s growing role in the industry, and new areas of <a href=\"https:\/\/allesleypharmacy.co.uk\/pharmacy\/product\/erythromycin\/\" data-internallinksmanager029f6b8e52c=\"52\" title=\"Erythromycin\">medicine<\/a> focused on longevity. <\/p>\n<p>Annabel also spoke with C\u00e9dric Moreau from Sofinnova Partners about the impact of the US midterm election results and what to expect in mergers and acquisitions (M&amp;A) in the biotech sector by 2027. Meanwhile, Jam Bensilum wrote about the future of longevity-focused biotech, noting that while investment in this area is at a record high, there are still challenges. For example, biological aging isn\u2019t yet recognized as a medical condition, and scientists are still figuring out how to measure its effects. This makes it harder to value companies in this field using traditional methods. You can read more about these insights here: [link].<\/p>\n<p>**US Midterm Elections and Their Impact on Pharma:**<br \/>\nThe recent US midterm elections are a hot topic in the pharmaceutical industry. Experts from companies like Jefferies, Model N, Hogan Lovells Cadwalader, Sofinnova Partners, and GlobalData Healthcare shared their thoughts on how increased Democratic influence in Congress could affect things like drug pricing, early-stage innovation, and how the <a href=\"https:\/\/www.fda.gov\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"fda\">FDA<\/a> (the agency that approves drugs) operates. You can listen to their detailed discussion here: [link].<\/p>\n<p>**China\u2019s Role in the Global Pharma Market:**<br \/>\nA recent panel discussion at the Financial Times Global Pharma &amp; Biotech \u2018China 2035\u2019 event focused on the COINS Act, a new law that could impact drug development and business deals involving Chinese biotech companies. The panel advised companies to stay flexible and continue pursuing partnerships, even as the law\u2019s details are still being finalized. Here are some key takeaways:<\/p>\n<p>&#8211; **No Slowdown Expected:** Companies like GSK are still actively looking for deals, similar to how they adapted to another law called BIOSECURE.<br \/>\n&#8211; **More Options for Buyers:** There are many promising Chinese biotech companies, which gives global partners more choices and stronger negotiating power. The most attractive deals will likely focus on innovative science, strong clinical evidence, and clear commercial potential.<br \/>\n&#8211; **Execution Matters:** Speed and quality in bringing drugs to market are crucial. Chinese biotech companies are increasingly proving that their clinical data is relevant for patients worldwide.<br \/>\n&#8211; **Partnerships Are Essential:** Chinese biotech firms still need global partners to help with international development and clinical trials.<br \/>\n&#8211; **Deal Structures Will Adapt:** While licensing deals will likely remain popular, expect more partnerships where companies work together to develop and improve drugs.<\/p>\n<p>The bigger question is whether this law will affect how investors fund new Chinese biotech companies. Established pharmaceutical companies may adapt, but it\u2019s unclear if venture capitalists (who fund early-stage companies) will feel the same way. <\/p>\n<p>**Growing Interest in Longevity Medicine:**<br \/>\nAt BIO-Europe, experts also discussed the rising interest in longevity-focused biotech. Investment in this area has reached an all-time high, but there are still hurdles. For example, current rules and regulations aren\u2019t designed to support treatments for aging itself\u2014they\u2019re mostly set up for drugs targeting specific diseases. Because of this, companies working on longevity drugs are still valued based on traditional methods, such as their potential to treat specific conditions.<\/p>\n<p>Experts predict that over the next 10 years, we\u2019ll see more progress in this field, including the development of drugs that target aging at a systemic level\u2014meaning they could address multiple aging-related issues at once. <\/p>\n<p>If you\u2019re interested in learning more about these topics, you can explore additional articles and resources from the BIO-Europe conference here: [link].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The pharmaceutical and biotech world is constantly evolving, and several important discussions and trends have recently come to light. Here\u2019s [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":3577,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[543],"tags":[],"class_list":["post-3576","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-news"],"_links":{"self":[{"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts\/3576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/comments?post=3576"}],"version-history":[{"count":1,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts\/3576\/revisions"}],"predecessor-version":[{"id":3585,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts\/3576\/revisions\/3585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/media\/3577"}],"wp:attachment":[{"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/media?parent=3576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/categories?post=3576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allesleypharmacy.co.uk\/pharmacy\/wp-json\/wp\/v2\/tags?post=3576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}